Abstract:Objective: To investigate the analytical performance verification protocols and performance specifications of platelet-dependent von Willebrand factor (VWF) activity testing (VWF:GPIbM) for clinical laboratories. Methods: According to Clinical Laboratory Standards Institute (CLSI) documents and National Health Standard of China, the performance verification of VWF:GPIbM was designed and implemented using Sysmex CS-5100 instrument and its corresponding reagents. (1) Precision verification: Two commercial quality control samples (with normal and low activity levels) and three plasma pools (with activity range from 5.0% to 150.0%) were prepared. Each sample was tested five times daily for five consecutive days. The coefficient of variation (CV) of intra-and inter-run precisions were calculated, and the precision evaluation criterion was set according to package inserts. (2) Trueness verification: The calibrator was diluted to five reference materials with activity values of 5.2%, 31.2%, 62.4%, 104.0% and 138.7%, and each reference material was tested five times daily for five consecutive days. The bias between the measured value and the reference value was calculated, and the trueness evaluation criterion was set according to the total allowable error. (3) Linearity verification: Ten pooled plasmas with theoretical value range from 3.6% to 160.4% were prepared for the linearity verification of two calibration curves set by the manufacturer (i.e. low range and normal range calibration curve). Each pooled plasma was tested three times in a single run. The slope and R2 of linear regression of mean of measured value and theoretical value, as well as bias, were calculated, and the linearity evaluation criterion was set according to National Health Standard of China and package inserts. (4) Limit of quantitation verification: The calibrator was diluted to two reference materials with activity values of 3.3% and 2.7%, and each material was tested twelve times. The limit of quantitation evaluation criterion was set according to CLSI document. Results: The CVs of intra-and inter-run were 1.0%-2.5% and 1.1%-2.6%, respectively. The biases of trueness verification were -0.4%, 1.0%, -2.6%, 0.3% and -2.7%, respectively. The linearity verification results of low range (3.6%-31.8%) and normal range (28.4%-160.4%) showed that the slopes of regression equation were 1.021 7 and 0.996 2, respectively, R2 were 0.993 5 and 0.993 9, respectively, and the biases with 0-1.8% and -10.1%-0 of plasmas met the criterion. The biases ranged from -0.4% to 0.3% of test results in the verification of limit of quantitation met the criterion. Conclusion: The verification results of VWF:GPIbM assay for precision, trueness, linearity and limit of quantification meet the performance requirements indicated in the package inserts and the criteria set in this study, which can be taken as a reference of performance verification for the clinical laboratories.

Evaluation of Automated Quantitative D-Dimer Test on the VIDAS Instrument

Performance Evaluation of the Sysmex CS-5100 Automated Coagulation Analyzer.

Analysis and Validation of AQT90 Testing System for Determination of D-Dimer in Human-Blood

Advances in D-dimer testing: progress in harmonization of clinical assays and innovative detection methods

The performance of quantitative D-dimer assays in Chinese clinical laboratories by analyzing data from National External quality Assessment Scheme

D-dimer—An International Assessment of the Quality of Laboratory Testing: Implications for D-dimer Use in the Real World

Abbott D-dimer assay: analytical performance and diagnostic accuracy in management of venous thromboembolism

Application of Innovance D-dimer in Clinical Settings with Cutoff Evaluated

A New Surface Plasmon Resonance-Based Immunoassay for Rapid and Sensitive Quantification of D-dimer in Human Plasma for Thrombus Screening

Method Comparison Between INNOVANCE D-Dimer and PLUS D-Dimer

Variable Performance of D-dimer Testing by Hemostasis Laboratories: The Australasian/Asia-Pacific Experience

Performance validation of hepatitis B virus DNA quantification by AUTRAX automatic nucleic acid extraction workstation

Comparison of four D‐dimer assays in the context of venous thromboembolism in the emergency department

Systematic review of diagnostic efficiency of laboratory tests used for disseminated intravascular coagulation

D-dimer testing: A narrative review

[Analytical Performance Verification Protocols and Performance Specifications of Platelet-Dependent Von Willebrand Factor Activity Testing].

Comparison of the results' consistency of 3 automated coagulation analyzers for coagulation items

Performance Evaluation of Clinical Detection of Coagulation Factors, Protein S, Protein C, Anti-thrombin Ⅲ, and von Willebrand Factor Antigen

Deep vein thrombosis and pulmonary embolism: a prospective, observational study to evaluate diagnostic performance of the Tina-quant D-Dimer Gen.2 assay

A new method of monitoring catheter-directed thrombolysis for deep venous thrombosis—application of D-dimer and fibrinogen testing

Performance verification of diluted thrombin time assay for detecting Dabigatran level in plasma